Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1959 Dec 12;2(5162):1307–1309. doi: 10.1136/bmj.2.5162.1307

Comparative Trials of New Oral Progestogenic Compounds in Treatment of Premenstrual Syndrome

Katharina Dalton
PMCID: PMC1990977  PMID: 13813862

Full text

PDF
1307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DALTON K. Similarity of symptomatology of premenstrual syndrome and toxaemia of pregnancy and their response to progesterone. Br Med J. 1954 Nov 6;2(4896):1071–1076. doi: 10.1136/bmj.2.4896.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FERIN J. Progestational activity of certain 19-nor steroids; comparative assays in oophorectomized women. J Clin Endocrinol Metab. 1957 Oct;17(10):1252–1255. doi: 10.1210/jcem-17-10-1252. [DOI] [PubMed] [Google Scholar]
  3. GREENBLATT R. B., JUNGCK E. C. Delay of menstruation with norethindrone, an orally given progestational compound. J Am Med Assoc. 1958 Mar 22;166(12):1461–1463. doi: 10.1001/jama.1958.62990120001011. [DOI] [PubMed] [Google Scholar]
  4. GREENE R., DALTON K. The premenstrual syndrome. Br Med J. 1953 May 9;1(4818):1007–1014. doi: 10.1136/bmj.1.4818.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gaunt R., Hays H. W. THE LIFE-MAINTAINING EFFECT OF CRYSTALLINE PROGESTERONE IN ADRENALECTOMIZED FERRETS. Science. 1938 Dec 16;88(2294):576–577. doi: 10.1126/science.88.2294.576. [DOI] [PubMed] [Google Scholar]
  6. HERTZ R., TULLNER W., RAFFELT E. Progestational activity of orally administered 17 alpha-ethinyl-19-nortestosterone. Endocrinology. 1954 Feb;54(2):228–230. doi: 10.1210/endo-54-2-228. [DOI] [PubMed] [Google Scholar]
  7. LANDAU R. L., BERGENSTAL D. M., LUGIBIHL K., KASCHT M. E. The metabolic effects of progesterone in man. J Clin Endocrinol Metab. 1955 Oct;15(10):1194–1215. doi: 10.1210/jcem-15-10-1194. [DOI] [PubMed] [Google Scholar]
  8. LANDAU R. L., LUGIBIHL K., BERGENSTAL D. M., DIMICK D. F. The metabolic effects of progesterone in man: dose response relationships. J Lab Clin Med. 1957 Oct;50(4):613–620. [PubMed] [Google Scholar]
  9. LANDAU R. L., LUGIBIHL K. Inhibition of the sodium-retaining influence of aldosterone by progesterone. J Clin Endocrinol Metab. 1958 Nov;18(11):1237–1245. doi: 10.1210/jcem-18-11-1237. [DOI] [PubMed] [Google Scholar]
  10. WIED G. L., DAVIS M. E. Comparative activity of progestational agents on the human endometrium and vaginal epithelium of surgical castrates. Ann N Y Acad Sci. 1958 Jul 30;71(5):599–616. doi: 10.1111/j.1749-6632.1958.tb46791.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES